|
1
|
Ducimetière F, Lurkin A, Ranchère-Vince D,
Decouvelaere AV, Péoc'h M, Istier L, Chalabreysse P, Muller C,
Alberti L, Bringuier PP, et al: Incidence of sarcoma histotypes and
molecular subtypes in a prospective epidemiological study with
central pathology review and molecular testing. PLoS One.
6:e202942011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fletcher CDM, Bridge JA, Hogendoorn P and
Mertens F: WHO classification of tumours of soft tissue and bone.
4th edition. IARC Press; Lyon: 2013
|
|
3
|
Kashu Y, Yukumi S, Tsunooka N, Tanigawa K,
Arakane M, Nakagawa H and Kawachi K: Successful resection of a
massive mediastinal liposarcoma that rapidly extended into the
entire left thoracic cavity: Report of a case. Surg Today.
42:68–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stevic R and Milenkovic B:
Tracheobronchial tumors. J Thorac Dis. 8:3401–3413. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Macchiarini P: Primary tracheal tumours.
Lancet Oncol. 7:83–91. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weaver J, Downs-Kelly E, Goldblum JR,
Turner S, Kulkarni S, Tubbs RR, Rubin BP and Skacel M: Fluorescence
in situ hybridization for MDM2 gene amplification as a diagnostic
tool in lipomatous neoplasms. Mod Pathol. 21:943–949. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dei Tos AP, Doglioni C, Piccinin S, Sciot
R, Furlanetto A, Boiocchi M, Dal Cin P, Maestro R, Fletcher CD and
Tallini G: Coordinated expression and amplification of the MDM2,
CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol.
190:531–536. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Singer S, Socci ND, Ambrosini G, Sambol E,
Decarolis P, Wu Y, O'Connor R, Maki R, Viale A, Sander C, et al:
Gene expression profiling of liposarcoma identifies distinct
biological types/subtypes and potential therapeutic targets in
well-differentiated and dedifferentiated liposarcoma. Cancer Res.
67:6626–6636. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kollar A and Benson C: Current management
options for liposarcoma and challenges for the future. Expert Rev
Anticancer Ther. 14:297–306. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nassif NA, Tseng W, Borges C, Chen P and
Eisenberg B: Recent advances in the management of liposarcoma.
F1000Res. 5:29072016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spinelli P, Pizzetti P, Lo Gullo C, Rocca
F, Gobbi A and Ravasi G: Resection of obstructive bronchial
fibrolipoma through the flexible fiberoptic bronchoscope.
Endoscopy. 14:61–63. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Patel RB, Li T, Liao Z, Jaldeepbhai JA,
Perera HAPNV, Muthukuda SK, Dhirubhai DH, Singh V, Du X and Yang J:
Recent translational research into targeted therapy for
liposarcoma. Stem Cell Investig. 4:212017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Laurino L, Furlanetto A, Orvieto E and Dei
Tos AP: Well-differentiated liposarcoma (atypical lipomatous
tumors). Semin Diagn Pathol. 18:258–262. 2001.PubMed/NCBI
|
|
14
|
Kammerer-Jacquet SF, Thierry S, Cabillic
F, Lannes M, Burtin F, Henno S, Dugay F, Bouzillé G, Rioux-Leclercq
N, Belaud-Rotureau MA and Stock N: Differential diagnosis of
atypical lipomatous tumor/well-differentiated liposarcoma and
dedifferentiated liposarcoma: utility of p16 in combination with
MDM2 and CDK4 immunohistochemistry. Hum Pathol. 59:34–40. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vargas DA, Takahashi S and Ronai Z: Mdm2:
A regulator of cell growth and death. Adv Cancer Res. 89:1–34.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oliner JD, Kinzler KW, Meltzer PS, George
DL and Vogelstein B: Amplification of a gene encoding a
p53-associated protein in human sarcomas. Nature. 358:80–83. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oliner JD, Pietenpol JA, Thiagalingam S,
Gyuris J, Kinzler KW and Vogelstein B: Oncoprotein MDM2 conceals
the activation domain of tumour suppressor p53. Nature.
362:857–860. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kato J, Matsushime H, Hiebert SW, Ewen ME
and Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene
product (pRb) and pRb phosphorylation by the cyclin D-dependent
kinase CDK4. Genes Dev. 7:331–342. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weinberg RA: The retinoblastoma protein
and cell cycle control. Cell. 81:323–330. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fåhraeus R, Paramio JM, Ball KL, Lain S
and Lane DP: Inhibition of pRb phosphorylation and cell-cycle
progression by a 20-residue peptide derived from p16CDKN2/INK4A.
Curr Biol. 6:84–91. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He M, Aisner S, Benevenia J, Patterson F,
Aviv H and Hameed M: p16 immunohistochemistry as an alternative
marker to distinguish atypical lipomatous tumor from deep-seated
lipoma. Appl Immunohistochem Mol Morphol. 17:51–56. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thway K, Flora R, Shah C, Olmos D and
Fisher C: Diagnostic utility of p16, CDK4, and MDM2 as an
immunohistochemical panel in distinguishing well-differentiated and
dedifferentiated liposarcomas from other adipocytic tumors. Am J
Surg Pathol. 36:462–469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pilotti S, Della Torre G, Mezzelani A,
Tamborini E, Azzarelli A, Sozzi G and Pierotti MA: The expression
of MDM2/CDK4 gene product in the differential diagnosis of well
differentiated liposarcoma and large deep-seated lipoma. Br J
Cancer. 82:1271–1275. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Binh MB, Sastre-Garau X, Guillou L, de
Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I and Coindre JM:
MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing
well-differentiated and dedifferentiated liposarcoma subtypes: A
comparative analysis of 559 soft tissue neoplasms with genetic
data. Am J Surg Pathol. 29:1340–1347. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Coindre JM, Mariani O, Chibon F, Mairal A,
De Saint Aubain Somerhausen N, Favre-Guillevin E, Bui NB, Stoeckle
E, Hostein I and Aurias A: Most malignant fibrous histiocytomas
developed in the retroperitoneum are dedifferentiated liposarcomas:
A review of 25 cases initially diagnosed as malignant fibrous
histiocytoma. Mod Pathol. 16:256–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Creytens D, van Gorp J, Ferdinande L, Van
Roy N and Libbrecht L: Array-based comparative genomic
hybridization analysis of a pleomorphic myxoid liposarcoma. J Clin
Pathol. 67:834–835. 2014. View Article : Google Scholar : PubMed/NCBI
|
